Discovery of 2-(4-Ureido-piperidin-1-yl)-4-morpholinothieno [3,2-D] Pyrimidines as Orally Bioavailable Phosphoinositide-3-Kinase Inhibitors with In Vitro and In Vivo Antitumor Efficacy in Triple-Negative Breast Cancer
Year: 2025
Type: article
Source: Journal of Medicinal Chemistry
Authors: Shabber Mohammed, Shabu Thakur, Diksha Manhas, Chilakala Nagarjuna Reddy, Abhisheik Eedara, Santosh K. Guru, Ajeet Singh, Mahir Bhardwaj, Vaishnavi Kambhampati, Ramajayan Pandian, Boobalan Gopu, Shashi Bhushan, Ram A. Vishwakarma, Sai Balaji Andugulapati, Shashank K. Singh, Utpal Nandi, Sandip B. Bharate
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Awards: G3560560345, G6255011972
OpenAlex ID: W4414856496
